Trifluoperazine
DrugBank ID: DB00831
Summary
| Metric | Value |
|---|---|
| Total Predictions | 50 |
| KG+DL (Dual Validated) | 0 |
| DL Only | 50 |
| KG Only | 0 |
Predictions
| Indication | Score | Source |
|---|---|---|
| manic bipolar affective disorder | 0.9951 | DL |
| schizophrenia | 0.9863 | DL |
| syndromic myopia | 0.9725 | DL |
| myopia X-linked | 0.9720 | DL |
| retinal dystrophy with or without extraocular anomalies | 0.9699 | DL |
| polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis | 0.9698 | DL |
| Charcot-Marie-Tooth disease, demyelinating, type 1G | 0.9691 | DL |
| congenital disorder of glycosylation with defective fucosylation | 0.9634 | DL |
| hydranencephaly (disease) | 0.9622 | DL |
| myopia 26, X-linked, female-limited | 0.9612 | DL |
| atypical glycine encephalopathy | 0.9570 | DL |
| bipolar disorder | 0.9436 | DL |
| major affective disorder | 0.9412 | DL |
| distal 17p13.3 microdeletion syndrome | 0.9379 | DL |
| agoraphobia | 0.9297 | DL |
| benign paroxysmal torticollis of infancy | 0.9273 | DL |
| anxiety disorder | 0.9257 | DL |
| psychotic disorder | 0.9133 | DL |
| REM sleep behavior disorder | 0.9043 | DL |
| treatment-refractory schizophrenia | 0.8971 | DL |
| psychosexual disorder | 0.8930 | DL |
| early-onset schizophrenia | 0.8892 | DL |
| hydrops-lactic acidosis-sideroblastic anemia-multisystemic failure syndrome | 0.8734 | DL |
| Malan overgrowth syndrome | 0.8175 | DL |
| schizophreniform disorder | 0.7715 | DL |
| childhood apraxia of speech | 0.7209 | DL |
| phobic disorder | 0.7082 | DL |
| trigeminal autonomic cephalalgia | 0.6811 | DL |
| dysthymic disorder | 0.6793 | DL |
| anxiety | 0.6691 | DL |
| headache disorder | 0.6677 | DL |
| enuresis | 0.6324 | DL |
| dissociative disorder | 0.6292 | DL |
| surfactant metabolism dysfunction, pulmonary | 0.6290 | DL |
| factitious disorder | 0.6200 | DL |
| trichotillomania | 0.6170 | DL |
| obsolete rare pulmonary disease | 0.5944 | DL |
| epidural abscess | 0.5900 | DL |
| major depressive disorder | 0.5793 | DL |
| specific developmental disorder | 0.5756 | DL |
| obsessive-compulsive disorder | 0.5717 | DL |
| striatal degeneration, autosomal dominant | 0.5712 | DL |
| attention deficit hyperactivity disorder, inattentive type | 0.5711 | DL |
| cholangiocarcinoma, susceptibility to | 0.5582 | DL |
| Tourette syndrome | 0.5568 | DL |
| tic disorder | 0.5552 | DL |
| polydipsia | 0.5493 | DL |
| ergotism | 0.5434 | DL |
| congenital cystic eye multiple ocular and intracranial anomalies | 0.5390 | DL |
| pyuria (disease) | 0.5325 | DL |
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.